In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Medtechs Won't Rest On Laurels After Excise Tax Victory

Executive Summary

In the polarized environment of Washington DC, the US medtech industry was becoming increasingly concerned as 2017 turned to 2018 that the medical device sales tax would be reinstated after a two-year suspension. AdvaMed chairman Nadim Yared tells In Vivo about the efforts and lobbying that got Congressmen onside just in time – but the battle doesn’t stop there.

Advertisement

Related Content

Murray Leaving Innovation Consortium, But Optimistic About Group's Future
Medicare Will Look To Informal Pathways For Faster Medtech Reimbursement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV005284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel